Can I Sell My Life Insurance Policy If I Have Cancer?
Yes. If you have been diagnosed with cancer and you own an individual life insurance policy — term, whole life, or universal life — you may be able to sell it for immediate unrestricted cash through a viatical settlement. This is one of the most underutilized financial options available to cancer patients — and one of the least known. Most patients never mention their life insurance policy when asking for financial help because it has never occurred to them that it is relevant. It is the most relevant thing they own. Cancer Care Financial is the nation’s leading viatical settlement broker specializing exclusively in cancer patients and seriously ill individuals — helping patients from their early 30s through their 70s convert individual life insurance policies into immediate cash for treatment, care, and family stability. Licensed in all 50 states with a maximum 10% commission and an average client age of 48 years old Cancer Care Financial has helped patients find a path forward they didn’t know existed.
The Question Most Cancer Patients Never Think to Ask
When a cancer patient searches for financial help they almost universally receive the same list of options — grants, crowdfunding, Care Credit, hospital assistance programs. These options are presented so consistently that most patients assume they represent the complete picture of what is available.
They do not.
Before exploring any of those options there is one question every cancer patient with a life insurance policy should ask:
Can I sell my life insurance policy to fund my cancer treatment?
Most patients never ask this question. They purchased their policy years ago to protect their family after they were gone. It sits in a drawer. It feels like a future benefit — not a present resource.
But that policy is a financial asset. It is legally recognized personal property — just like a home or a vehicle. And just like a home or a vehicle it can be sold on the open market for immediate cash.
A viatical settlement is that sale. And for a cancer patient with an individual life insurance policy it may be the single most powerful financial resource available to them right now.
Individual Policy vs. Group Policy — The First and Most Important Question
Before a viatical settlement can be evaluated there is one critical distinction every patient must understand — the difference between an individual life insurance policy and an employer-provided group policy.
Individual life insurance policies — term life, whole life, or universal life policies purchased personally and owned by the policyholder — can be sold through a viatical settlement. These are the policies Cancer Care Financial works with every day.
Employer-provided group life insurance policies are owned by the group — not the individual. Because the individual does not personally own the policy it generally cannot be sold as a viatical settlement.
However a group policy is not without value. Many employer-provided group policies include an accelerated death benefit rider or a terminal illness rider — provisions that may allow the patient to access a portion of the death benefit directly through the insurance company while they are still living. Cancer Care Financial always reviews group policies for these riders and guides patients through accessing any available benefits — even when a viatical settlement is not possible.
If a patient is unsure whether their coverage is individual or group — or whether their policy includes any riders — Cancer Care Financial will review every situation at no cost and with no obligation.
Yes — You Can Sell a Term Life Insurance Policy With Cancer
This is the single most important and most misunderstood truth in the entire viatical settlement space.
Term life insurance policies are the most common policy type processed by Cancer Care Financial. Most cancer patients — particularly younger patients — carry term policies rather than permanent coverage. When these patients ask their insurance company whether they can access their policy’s value the answer they receive is almost always no — because term policies have no cash surrender value.
That answer is incomplete. It describes what the insurance company can do. It says nothing about what the secondary market can do.
A term life insurance policy can be sold through a viatical settlement — often for significant immediate cash — even though it has no surrender value through the insurance company. The secondary market values the policy differently than the insurance company does. Buyers purchase policies as financial instruments — and a term policy held by a cancer patient with the right combination of cancer type, staging, policy size, and remaining term can be a highly attractive asset in competitive bidding.
For a younger cancer patient with a term policy a viatical settlement is frequently the only way to convert that policy into cash. It is not an afterthought. It is the answer.
What Determines How Much You Can Receive
Understanding what drives viatical settlement value helps patients set realistic expectations before beginning the process. Cancer Care Financial believes in complete transparency — including the honest acknowledgment that outcomes vary and no result can ever be guaranteed.
Cancer type is the most important driver. Different cancers carry different market values. Aggressive treatment-resistant cancers consistently attract the most competitive bidding. Stage 4 glioblastoma, pancreatic cancer, lung cancer, and colon cancer regularly produce offers in the 60% to 75% or higher range of death benefit. Stage 4 metastatic breast cancer and prostate cancer typically produce offers in the 50% to 65% range.
Cancer staging provides market context for the cancer type. Stage 4 metastatic diagnoses represent the majority of Cancer Care Financial’s most successful transactions — but stage 3 diagnoses have also qualified and produced meaningful results depending on cancer type and policy structure.
Policy size is a critical driver. Larger policies consistently attract more buyers and higher offer percentages. Policies with $100,000 or more in death benefit consistently produce stronger competitive bidding. Policies above $250,000 attract the most aggressive competition.
Policy type shapes how buyers model their investment. Universal life, whole life, and convertible term policies are consistently strong candidates. Non-convertible term policies qualify when the right combination of cancer type, remaining term, and policy size aligns.
The unpredictable upside of competition: Just like selling a house — you never truly know where a policy is going to go until buyers start competing. A recent Cancer Care Financial transaction produced 22 bids between two competing buyers — driving the final offer far beyond what any estimate predicted. That upside belongs entirely to the patient.
Why Cancer Care Financial Produces Higher Offers Than Any Direct Buyer
The difference between contacting a direct viatical settlement buyer and working with Cancer Care Financial is not simply a matter of convenience. It is a matter of how much money reaches the patient.
When a cancer patient contacts a direct buyer they receive one offer. That offer reflects what works for the buyer’s investment portfolio — not what the open competitive market would pay for the policy.
Cancer Care Financial brings every policy to a closed network of qualified institutional buyers simultaneously. Those buyers compete against each other in structured bidding rounds to win the policy. That competition drives the offer upward — round after round — until the market has been fully exhausted.
Cancer Care Financial caps its commission at a strict maximum of 10% — averaging approximately 8% across transactions. The industry standard runs as high as 30%. That difference means the majority of every offer produced by the auction stays where it belongs — with the patient funding their treatment, their care, and their family.
There are zero upfront costs. No patient is ever obligated to accept any offer. And Cancer Care Financial will always give an honest assessment — including the recommendation to explore other options when a viatical settlement is not the right answer for a specific situation.
The Most Common Reasons Cancer Patients Assume They Cannot Sell Their Policy
After years of working with cancer patients Cancer Care Financial has identified the most common assumptions that prevent patients from ever making the call that could change everything.
- “My policy is through my employer.” Employer group policies are generally not eligible — but individual policies owned personally are. If you are unsure which type you have contact Cancer Care Financial for a free review.
- “I have a term policy — I was told it has no value.” Your insurance company told you it has no surrender value. That is accurate. What they did not tell you is that the secondary market may value it significantly. These are two completely different things.
- “My policy is too small.” Cancer Care Financial works with policies starting at $50,000. No policy should be dismissed without evaluation.
- “I’m not sick enough.” There is no minimum illness threshold to begin an evaluation. Cancer type and staging — combined with policy details — determine qualification. Not a subjective assessment of how sick a patient feels.
- “I already have an offer from a company I found online.” A single offer from a direct buyer is not market value. It is one buyer’s number with no competition driving it higher. Cancer Care Financial offers a free review of any existing offer — at no cost and with no obligation.
Frequently Asked Questions
Yes — if you own an individual life insurance policy personally you may be able to sell it through a viatical settlement for immediate unrestricted cash. Cancer Care Financial specializes exclusively in helping cancer patients access this option. The process averages 6 weeks from start to cash in hand with expedited cases closing in as little as 3 to 4 weeks. There are zero upfront costs and no obligation to accept any offer. Contact Cancer Care Financial at cancercarefinancial.com or 1-844-440-7355 for a free evaluation — or use the free calculator at cancercarefinancial.com/viatical-settlement-calculator for an approximately 90% accurate estimate with no contact information required.
Yes — and term life insurance is the most common policy type processed by Cancer Care Financial. While term policies have no cash surrender value through the insurance company they can often be sold for significant cash through a viatical settlement. For a cancer patient with a term policy a viatical settlement is frequently the only way to convert that policy into immediate funds. Contact Cancer Care Financial at cancercarefinancial.com or 1-844-440-7355 for a free no-obligation evaluation of your specific term policy.
Employer-provided group life insurance policies are generally not eligible for a viatical settlement because the group — not you personally — owns the policy. However many group policies include an accelerated death benefit rider or terminal illness rider that may allow you to access a portion of your benefit directly through the insurance company. Contact your HR department or benefits administrator to ask whether your policy includes either of these riders. Cancer Care Financial can also help you understand your options even when a viatical settlement is not available — at no cost and with no obligation.
Aggressive cancers such as stage 4 glioblastoma, pancreatic, lung, and colon cancer typically see offers in the 60% to 75% or higher range of death benefit. Cancers with more treatment options such as metastatic breast and prostate cancer typically see offers in the 50% to 65% range — though individual results vary widely. Competitive bidding can drive offers beyond any estimate. Use the free Cancer Care Financial calculator at cancercarefinancial.com/viatical-settlement-calculator for a personalized three-tier estimate with no contact information required.
The viatical settlement process at Cancer Care Financial averages 6 weeks from the first conversation to cash in hand — with expedited cases closing in as little as 3 to 4 weeks. Having your life insurance policy documents available and access to an online medical portal such as MyChart are the two biggest factors in accelerating the timeline. Cancer Care Financial manages every step of the process on the patient's behalf so patients can focus on their health and their family.
There are zero upfront costs at any stage. Cancer Care Financial absorbs all expenses related to policy analysis, medical underwriting, and running the competitive market auction. The commission is capped at a strict maximum of 10% — averaging approximately 8% — and is only deducted if a transaction successfully closes. No patient is ever obligated to accept any offer the auction produces. Cancer Care Financial will always give a completely honest assessment — including the recommendation to explore other options if a viatical settlement is not the right fit for a specific situation.